Comparison [acty]    
Long-Term Effects [phpr]    
Alpha [inpr]    
Recombinant Interferon Alfa therapy [topp]    
Patients [podg]    
Hepatitis B, Chronic [dsyn]    
Long-Term Effect [phpr]    
Natural [ftcn]    
Alpha [inpr]    
recombinant [orgm]    
therapy [ftcn]    
Patients [podg]    
Hepatitis B, Chronic [dsyn]    
Patients [podg]    
Trial [resa]    
1-5 years [fndg]    
Following [tmco]    
End [spco]    
therapy [ftcn]    
included [ftcn]    
Patients [podg]    
RECEIVED [qlco]    
Placebo [topp]    
control [qlco]    
Treated [ftcn]    
Priming [ftcn]    
Treated [ftcn]    
Priming [ftcn]    
Cumulative [qlco]    
Sustained [ftcn]    
Response [orga]    
Higher [qlco]    
Patients [podg]    
Treated [ftcn]    
Priming [ftcn]    
Exhibit [inpr]    
Alone [qnco]    
Alone [qnco]    
Placebo [topp]    
Following [tmco]    
Priming [ftcn]    
End [spco]    
YEARS [tmco]    
HEPATOCELLULAR CARCINOMA [neop]    
Detected [fndg]    
Group [idcn]    
Group [idcn]    
14 7 [qnco]    
Control Group [grup]    
control [qlco]    
Cumulative [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Higher [qlco]    
Control Group [grup]    
Group [idcn]    
Group [idcn]    
Cumulative Survival Rate [qnco]    
LOWER [spco]    
Control Group [grup]    
Group [idcn]    
Group [idcn]    
Revealed [qlco]    
therapy [ftcn]    
Female Gender [orga]    
Sustained [ftcn]    
Response [orga]    
Preexisting [qlco]    
CIRRHOSIS [dsyn]    
Entry [inpr]    
therapy [ftcn]    
HEPATOCELLULAR CARCINOMA [neop]    
Survival [acty]    
treatment [ftcn]    
Long-Term Effect [phpr]    
HEPATITIS B VIRUS [virs]    
Clearance [qlco]    
Placebo [topp]    
therapy [ftcn]    
Long-Term Effects [phpr]    
Placebo [topp]    
HEPATITIS B VIRUS [virs]    
Clearance [qlco]    
Reduction [npop]    
HEPATOCELLULAR CARCINOMA [neop]    
Prolonged [tmco]    
Survival [acty]    
